For more please check https://www.bocsci.com/holding....-hands-using-peptide
پسندیدن
اظهار نظر
اشتراک گذاری
Nov
27
Dr Kelly's team synthesized a PDC series of PDCs designed to treat pulmonary fibrosis precisely, combining the kinase inhibitor nintedanib with a mimetic peptide chain targeting the αVβ6 integrin. Their antifibrotic activity is currently being evaluated in a mouse model of pulmonary fibrosis.
27-11-24 - 10:00 تاریخ شروع
27-11-24 - 16:00 تاریخ پایان
New York, NY 11967
بارگذاری پست های بیشتر